Bioqual, Inc. (BIOQ)
OTCMKTS · Delayed Price · Currency is USD
31.00
+0.36 (1.17%)
At close: Oct 28, 2026
Bioqual Revenue
Bioqual had revenue of $10.15M in the quarter ending August 31, 2026, with 2.97% growth. This brings the company's total for the last twelve months to $40.24M, down -14.30% year-over-year. In the fiscal year ending May 31, 2026, Bioqual had annual revenue of $39.95M, down -18.25%. That makes Bioqual the 29,486th largest company in the world by revenue and 3,920th in the United States.
Revenue (ttm)
40.24M
Revenue Growth
-14.30%
P/S Ratio
0.69
Revenue / Employee
356.11K
Employees
113
Market Cap
27.73M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| May 31, 2026 | 39.95M | -8.92M | -18.25% |
| May 31, 2025 | 48.87M | -9.72M | -16.60% |
| May 31, 2024 | 58.59M | -4.07M | -6.50% |
| May 31, 2023 | 62.66M | -3.49M | -5.27% |
| May 31, 2022 | 66.15M | 8.47M | 14.68% |
| May 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Global Cord Blood | 196.10M |
| Interpace Biosciences | 36.14M |
| Psychemedics | 19.69M |
| Aspira Women's Health | 8.55M |
| IDenta | 1.86M |
| Longduoduo Company | 1.82M |
| InVitro International | 878.94K |
| NovelStem International | 3.00K |
Bioqual News
- 19 days ago - BIOQUAL Presents Unaudited Financial Results for First Quarter of Fiscal Year 2027 - Business Wire
- 5 weeks ago - CORRECTING and REPLACING BIOQUAL Presents Financial Results for Fiscal Year 2026 - Business Wire
- 7 weeks ago - BIOQUAL Presents Financial Results for Fiscal Year 2026 - Business Wire
- 6 months ago - BIOQUAL Presents Unaudited Financial Results for Third Quarter of Fiscal Year 2026 - Business Wire
- 9 months ago - BIOQUAL Presents Unaudited Financial Results for Second Quarter of Fiscal Year 2026 - Business Wire
- 1 year ago - BIOQUAL Presents Unaudited Financial Results for First Quarter of Fiscal Year 2026 - Business Wire
- 1 year ago - BIOQUAL Presents Financial Results for Fiscal Year 2025 - Business Wire
- 1 year ago - BIOQUAL Announces the retirement of Dr. Mark G. Lewis as President and CEO of the company - Business Wire